Journal article · 2013 · Open access
Drivers and barriers to patient participation in RCTs
British Journal of Cancer, 108(7), 1402–1407 · Published 19 March 2013 · DOI 10.1038/bjc.2013.113
In brief
“Drivers and barriers to patient participation in RCTs” is a 2013 journal article by Valerie A. Jenkins and 6 co-authors, published in British Journal of Cancer. OpenAlex counts 118 citations as of 22 November 2026. It is open access under a CC BY-NC-SA licence: the full text is free to read at British Journal of Cancer.
- Citations
- 118
- Most cited in
- 2020 (13)
- Field-weighted impact
- 10.06
- References
- 12
- Authors
- 7
Abstract
BACKGROUND: Recruitment of patients into randomised clinical trials (RCTs) is essential for treatment evaluation. Appreciation of the barriers and drivers towards participation is important for trial design, communication and information provision. METHOD: As part of an intervention to facilitate effective multidisciplinary team communication about RCTs, cancer patients completed two study-specific questionnaires following trial discussions. One questionnaire examined reasons why patients accepted or declined trial entry, the other perceptions about their health-care professionals' (HCPs) information giving. RESULTS: Questionnaires were completed by 74% (358/486) of patients approached; of these 81% (291/358) had joined an RCT, 16% (56/358) had declined and 3% (11/358) were undecided. Trial participation status of the 128 patients not returning questionnaires is unknown. Trial acceptance was not dependent on disease stage, tumour type, sex or age. Satisfaction with trial information and HCPs' communication was generally very good, irrespective of participation decisions. The primary reason given for trial acceptance was altruism (40%; 110/275), and for declining, trust in the doctor (28%; 12/43). Decliners preferred doctors to choose their treatment rather than be randomised (54% vs 39%; P<0.027). Acceptors were more likely to perceive doctors as wanting them to join trials (54% vs 30%; P<0.001). Trial type, that is, standard treatment vs novel or different durations of treatment, also influenced acceptance rates. CONCLUSION: The drivers and barriers to trial participation are partly related to trial design. Unease about randomisation and impact of duration on treatment efficacy are barriers for some. Altruism and HCPs' perceived attitudes are powerful influencing factors.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Jenkins, V. A., Farewell, V. T., Farewell, D. M., Darmanin, J., Wagstaff, J., Langridge, C., & Fallowfield, L. J. (2013). Drivers and barriers to patient participation in RCTs. British Journal of Cancer, 108(7), 1402–1407. https://doi.org/10.1038/bjc.2013.113
MLA 9
Jenkins, Valerie A., et al. “Drivers and barriers to patient participation in RCTs.” British Journal of Cancer, vol. 108, no. 7, 2013, pp. 1402–1407. https://doi.org/10.1038/bjc.2013.113.
Chicago
Jenkins, Valerie A., Vernon Todd Farewell, Daniel Mark Farewell, J Darmanin, John Wagstaff, C. Langridge, and Lesley J. Fallowfield. 2013. “Drivers and barriers to patient participation in RCTs.” British Journal of Cancer 108 (7): 1402–1407. https://doi.org/10.1038/bjc.2013.113.
Harvard
Jenkins, V. A. et al. (2013) ‘Drivers and barriers to patient participation in RCTs’, British Journal of Cancer, 108(7), pp. 1402–1407. doi:10.1038/bjc.2013.113.
IEEE
V. A. Jenkins et al., “Drivers and barriers to patient participation in RCTs,” British Journal of Cancer, vol. 108, no. 7, pp. 1402–1407, 2013, doi: 10.1038/bjc.2013.113.
BibTeX
@article{jenkins2013drivers,
title = {{Drivers and barriers to patient participation in RCTs}},
author = {Jenkins, Valerie A. and Farewell, Vernon Todd and Farewell, Daniel Mark and Darmanin, J and Wagstaff, John and Langridge, C. and Fallowfield, Lesley J.},
journal = {British Journal of Cancer},
year = {2013},
volume = {108},
number = {7},
pages = {1402--1407},
doi = {10.1038/bjc.2013.113},
url = {https://doi.org/10.1038/bjc.2013.113}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 5 | |
| 2018 | 6 | |
| 2019 | 8 | |
| 2020 | 13 | |
| 2021 | 9 | |
| 2022 | 10 | |
| 2023 | 9 | |
| 2024 | 4 | |
| 2025 | 8 | |
| 2026 | 8 |
Its field-weighted citation impact is 10.06: it has been cited 10.06 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- patient recruitment
- randomized controlled trials
- clinical trial participation
- cancer patients
- altruism
- trust in physicians
- health care professional communication
- trial design
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Jenkins, V. A., Farewell, V. T., Farewell, D. M., Darmanin, J., Wagstaff, J., Langridge, C., & Fallowfield, L. J. (2013). Drivers and barriers to patient participation in RCTs. British Journal of Cancer, 108(7), 1402–1407. https://doi.org/10.1038/bjc.2013.113
How many times has this paper been cited?
118 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at British Journal of Cancer: sign in and open the PDF from this page.
Who wrote this paper?
Valerie A. Jenkins, Vernon Todd Farewell, Daniel Mark Farewell, J Darmanin, John Wagstaff, C. Langridge, Lesley J. Fallowfield.
What is the DOI of this paper?
10.1038/bjc.2013.113, permanently at https://doi.org/10.1038/bjc.2013.113. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.